Liu, Wen-Yang
Shi, Jin-Ming
Li, Ning
Wang, Xin
Gao, Yuan-Hong
Chi, Yihebali
Sun, Yong-Kun
Zhao, Qing
Zhu, Yong-Jian
Chen, Hong-Da
Fang, Hui
Lu, Ning-Ning
Qi, Shu-Nan
Chen, Bo
Wang, Shu-Lian
Song, Yong-Wen
Liu, Yue-Ping
Li, Ye-Xiong
Liu, Zheng
Zhou, Hai-Tao
Liang, Jian-Wei
Wang, Xi-Shan
Zhang, Hai-Zeng
Tang, Yuan
Jin, Jing
Funding for this research was provided by:
Beijing Municipal Science & Technology Commission (Z181100001718136)
Beijing Hope Run Special Fund of Cancer Foundation of China (LC2018A24)
National Natural Science Foundation of China (82073352)
Article History
Received: 10 October 2022
Accepted: 16 December 2022
First Online: 28 December 2022
Declarations
:
: This study met the rapid review conditions and institutional review board approval was obtained for this trial from the ethical committee of the Chinese Academy of Medical Sciences.
: Not applicable.
: There are neither relationships with industry and organizations in this study, nor potential conflicts of interest between authors and other persons.